Cohance Lifesciences, Suven Pharmaceuticals merger sanctioned by the NCLT
The Company expects to complete the amalgamation process by Q1FY26
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Cohance Lifesciences
Cohance, Suven merger get approval from NSE and BSE
The newly formed company will operate three main verticals: Pharma CDMO, Agrochemicals CDMO, and API manufacturing
Suven, Cohance announce merger
The merged platform to comprise three distinct business units – Pharma CDMO, Spec Chem CDMO, and API+ (inclusive of formulations)
Advent International launches Cohance Lifesciences
Cohance Lifesciences is a new brand identity for Advent International's API platform